This protein has surprising powers against obesity

Scientists have discovered that a molecule naturally occurring in many living organisms can be turned into a powerful weapon against obesity and reduce the chance of developing obesity-related diseases.

Sparrow
sparrow.science
3 min readNov 5, 2018

--

In 10 seconds? Cancer researchers have chanced upon a protein, that can significantly ramp up metabolism and fight weight gain, as it drastically reduced fat in animal tests. (Read the science)

What did they discover? Scientists were investigating the role of a group of proteins in cancer, but discovered instead how powerful one of them was in breaking down fat. This molecule revs up metabolism: lab mice treated with it lost one third of their fat and it cleared up their fatty livers. (Read the paper)

How did they do it? The mice were given 8 treatments of FGFBP3 — a protein naturally present in many mammals, including humans. In just 18 days, researchers saw a dramatic drop in the animals’ fat level and also a reduction in obesity-related disorders. The treatment cut excess blood sugar levels too, which are linked to type 2 diabetes and fatty liver disease. (More on the FGF group of proteins)

So, what are these magic proteins? Fat-busting BP3 belongs to a group called fibroblast growth factors (FGF). These proteins are present in many species, but so far have only been known to regulate cell growth and wound healing. BP3 was found to speed up how cells store or burn fats and sugars.

Great, but shouldn’t we just eat less and move more? True, counting calories can regulate weight gain, but that’s easier said than done. Scientists have proved that genes in our brain regulate the sense of hunger, and an adverse genetic combination can make us crave for much more than we need. They also identified two groups of brain cells. One tells us to stop eating when we’re full, the other to carry on… and guess which one often wins the argument? (More on this)

Are genetics such a big contributor? Yes! A large proportion of people carry genetic mutations that put them at risk of becoming obese. An estimated one third of the world’s population is obese,and high body mass index (BMI) contributes to millions of deaths every year. So predicting who is at risk can lead to therapies for those who are unable to control their weight otherwise.

So when will all this become a therapy? As BP3 naturally occurs in the human body, clinical testing will be faster than with synthetic drug molecules, so watch this space! Additionally, there’s good news for a small proportion of people who are genetically predisposed to become obese from childhood (monogenic obesity) and don’t respond to treatments like others do. A study has found that taking a modified appetite-inhibiting hormone reduced their weight by 7 kg on average. (Read more).

Research curated by Endre Szvetnik, Senior Editor at Sparrho.

Endre works with Sparrho Heroes to curate, translate and disseminate scientific research to the wider public.

(Psst, Endre distilled 17 research papers to save you 881.2 min)

Originally published at www.sparrho.com.

--

--

Sparrow
sparrow.science

Steve, the sparrow, represents contributions from the Sparrow Team and our expert researchers. We accredit external contributors where appropriate.